Energy balance

Pharmacological inhibition or genetic deficiency of Stearoyl-CoA desaturase 1 (SCD1) reduces body adiposity and prevents diet-induced obesity by increasing energy expenditure and fatty acid oxidation.

Current research suggests that targeting the SCD1 enzyme could be a viable strategy for treating obesity. In animal models, reducing SCD1 activity leads to increased fat burning and resistance to weight gain, even with high food intake. While not yet a human treatment, this highlights the importance of lipid metabolism enzymes in body weight regulation.